Publisher: Wiley-Blackwell

Related content
Volume 62, Number 2, February 2007

< previous issue | all issues | next issue >

Favourites:Add to Favourites

Asthma control or severity: that is the question
pp. 95-101(7)
Authors: Humbert, M.; Holgate, S.; Boulet, L.-P.; Bousquet, J.

Favourites:Add to Favourites

GINA guidelines on asthma and beyond
pp. 102-112(11)
Authors: Bousquet, J.; Clark, T. J. H.; Hurd, S.; Khaltaev, N.; Lenfant, C.; O'Byrne, P.; Sheffer, A.

Favourites:Add to Favourites
Favourites:Add to Favourites

Control and severity: complementary approaches to asthma management
pp. 116-119(4)
Authors: Roche, N.; Godard, P.

Favourites:Add to Favourites

Quantification of asthma control: validation of the Asthma Control Scoring System
pp. 120-125(6)
Authors: LeBlanc, A.; Robichaud, P.; Lacasse, Y.; Boulet, L.-P.

Favourites:Add to Favourites

Extent, patterns, and burden of uncontrolled disease in severe or difficult-to-treat asthma
pp. 126-133(8)
Authors: Sullivan, S. D.; Rasouliyan, L.; Russo, P. A.; Kamath, T.; Chipps, B. E.

Favourites:Add to Favourites

The limitations of severe asthma: the results of a European survey
pp. 134-141(8)
Authors: Dockrell, M.; Partridge, M. R.; Valovirta, E.

Favourites:Add to Favourites

Asthma score: predictive ability and risk factors
pp. 142-148(7)
Authors: Sunyer, J.; Pekkanen, J.; Garcia-Esteban, R.; Svanes, C.; Künzli, N.; Janson, C.; de Marco, R.; Antó, J. M.; Burney, P.

Favourites:Add to Favourites

Cost-effectiveness of omalizumab in patients with severe persistent allergic asthma
pp. 149-153(5)
Authors: Brown, R.; Turk, F.; Dale, P.; Bousquet, J.

Favourites:Add to Favourites

Omalizumab decreases nonspecific airway hyperresponsiveness in vitro
pp. 154-161(8)
Authors: Berger, P.; Scotto-Gomez, E.; Molimard, M.; Marthan, R.; Le Gros, V.; Tunon-de-Lara, J. M.

Favourites:Add to Favourites

T-cell activation in occupational asthma and rhinitis
pp. 162-169(8)
Authors: Mamessier, E.; Milhe, F.; Guillot, C.; Birnbaum, J.; Dupuy, P.; Lorec, A.-M.; Vervloet, D.; Magnan, A.

Favourites:Add to Favourites

Chemokine receptor expression on allergen-specific T cells in asthma and allergic bronchopulmonary aspergillosis
pp. 170-177(8)
Authors: Garcia, G.; Humbert, M.; Capel, F.; Rimaniol, A. C.; Escourrou, P.; Emilie, D.; Godot, V.

Favourites:Add to Favourites
Favourites:Add to Favourites

Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis
pp. 184-189(6)
Authors: Bieber, T.; Vick, K.; Fölster-Holst, R.; Belloni-Fortina, A.; Städtler, G.; Worm, M.; Arcangeli, F.

Favourites:Add to Favourites

Design, engineering and in vitro evaluation of MHC class-II targeting allergy vaccines
pp. 197-206(10)
Authors: Crameri, R.; Flückiger, S.; Daigle, I.; Kündig, T.; Rhyner, C.

Favourites:Add to Favourites

Correlation among FEV1, nitric oxide and asthma control test in newly diagnosed asthma
pp. 207-208(2)
Authors: Senna, G.; Passalacqua, G.; Schiappoli, M.; Lombardi, C.; Wilcock, L.

Favourites:Add to Favourites

Association between a genetic variation of CC chemokine receptor-2 and atopic asthma
pp. 208-209(2)
Authors: Kim, Y.-K.; Oh, H.-B.; Lee, E.-Y.; Gho, Y. S.; Lee, J.-E.; Kim, Y.-Y.

Favourites:Add to Favourites

Anaphylaxis to kangaroo meat – identification of a new marsupial allergen
pp. 209-211(3)
Authors: Boyle, R. J.; Russo, V. C.; Andaloro, E.; Mehr, S. M.; Tang, M. L.-K.

Favourites:Add to Favourites

Occupational asthma due to spores of Pleurotus ostreatus
pp. 211-212(2)
Authors: Vereda, A.; Quirce, S.; Fernández-Nieto, M.; Bartolomé, B.; Sastre, J.

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more